Mantle cell lymphoma: open trials in South Korea

• NCT06084936

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Chungnam National University Hospital, Daejeon · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-11-05

• NCT07101328

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  Trial Treatment · Phase 1 · Eli Lilly and Company

  Asan Medical Center, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-04

• NCT06742996

  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  Trial Treatment · Phase 3 · BeOne Medicines

  Samsung Medical Center, GangnamGu · The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu · Pusan National University Hospital, Seogu · Seoul National University Hospital, Seoul · Asan Medical Center, SongpaGu · The Catholic University of Korea, Yeouido St Marys Hospital, Yeongdeungpo-gu

  Registry updated 2026-10-29

• NCT06564038

  A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

  Trial Treatment · Phase 1/2 · AstraZeneca

  Busan · Seoul

  Registry updated 2026-10-28

• NCT05006716

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  Trial Treatment · Phase 1/2 · BeOne Medicines

  Samsung Medical Center, GangnamGu · The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu · Severance Hospital Yonsei University Health System, SeodaemunGu · Pusan National University Hospital, Seogu · Seoul National University Hospital, Seoul · Asan Medical Center, SongpaGu

  Registry updated 2026-10-05

• NCT05245656

  A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

  Trial Treatment · Phase 2 · Kim, Seok Jin

  Samsung Medical Center, Seoul

  Registry updated 2026-04-23

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error